Polcythemia vera (PV)

MITHRIDATE

What is the study about?

The aim of this research study is to test how safe and effective a drug called ruxolitinib is when treating patients with PV when compared to the current Best Available Therapy (BAT).

Who can take part?

People with high risk PV

How do I take part?

Please discuss with your doctor at your next clinic appointment.

More information

Visit the study website.